VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BKYI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BKYIBIO-key International, Inc.
$4.60$3M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBKYIFinancials

BIO-key International, Inc. (BKYI) Financials

30Y historyFree accessUpdated daily

Revenue remains highly volatile, fluctuating between $0.9M and $2.2M over the last ten quarters, while the company continues to report negative operating margins, reaching -5.5% in 2026Q1.

BKYI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue6.63M6.1M6.93M7.75M7.02M5.11M2.84M2.27M4.04M6.3M2.98M5.26M4.01M1.99M3.84M3.51M3.52M2.36M12.88M9.99M15.19M14.23M5.56M524.1K155.4K00157.97K384.58K464.17K32K
Revenue Growth %4.37%-12.04%-10.64%10.46%37.26%80.29%25.1%-43.94%-35.83%111.81%-43.44%31.34%101.71%-48.23%9.32%-0.33%49.34%-81.69%28.91%-34.26%6.8%155.95%960.53%237.26%---100%-58.92%-17.15%1350.53%-
Cost of Goods Sold1.47M1.37M1.29M6.32M2.44M1.67M794.83K2.46M4.16M6.48M729.68K1.28M748.75K387.03K571.73K810.46K559.14K504.24K1.74M1.78M3.4M3.84M2.06M89.08K2.72K0-137.3K-33.19K1.05M390.24K14.88K
COGS % of Revenue-22.53%18.61%81.54%34.75%32.71%28.02%108.54%102.96%102.88%24.52%24.32%18.69%19.49%14.9%23.1%15.88%21.39%13.48%17.87%22.36%27.02%37.14%17%1.75%---21.01%274.21%84.07%46.48%
Gross Profit5.16M4.72M5.64M1.43M4.58M3.44M2.04M-193.72K-119.65K-181.32K2.25M3.98M3.26M1.6M3.26M2.7M2.96M1.85M11.14M8.2M11.8M10.38M3.49M435.02K152.68K0137.3K191.16K-669.97K73.92K17.13K
Gross Margin %77.84%77.47%81.39%18.46%65.25%67.29%71.98%-8.54%-2.96%-2.88%75.48%75.68%81.31%80.51%85.1%76.9%84.12%78.61%86.52%82.13%77.64%72.98%62.86%83%98.25%--121.01%-174.21%15.93%53.52%
Gross Profit Growth %--16.28%294.06%-68.75%33.1%68.54%1154.09%-61.91%34.01%-108.07%-43.59%22.25%103.7%-51.02%20.97%-8.88%59.81%-83.37%35.8%-30.46%13.62%197.15%703.18%184.92%--100%-28.17%128.53%-1006.28%331.68%-
Operating Expenses8.9M8.98M9.65M10.26M14.5M8.38M7.25M13.33M6.75M7.34M6.45M5.68M5.3M4.12M3.24M4.15M4.16M4.31M11.04M13.57M16.83M18.67M10.08M3.16M3.01M2.27M3.13M3.49M4.88M2.86M809.29K
OpEx % of Revenue-147.37%139.28%132.27%206.61%163.92%255.4%587.69%166.87%116.39%216.65%107.9%132.21%207.49%84.37%118.36%118.2%182.83%85.76%135.84%110.74%131.24%181.28%602.07%1937.49%--2211.78%1270.15%616.2%2529.04%
Selling, General & Admin6.27M6.37M7.14M7.86M9.36M6.03M5.85M5.04M5.33M5.68M4.44M4.12M3.67M2.78M2.29M3.04M3.11M3.38M6.55M8.57M10.31M11.82M7.1M2.12M1.93M1.32M1.85M2.15M3.31M2.3M422.68K
SG&A % of Revenue-104.55%103.04%101.39%133.4%117.87%206.17%222.13%131.88%90.06%149.14%78.33%91.62%139.81%59.67%86.53%88.21%143.5%50.9%85.84%67.86%83.12%127.67%404.14%1239.6%--1361.95%861.9%494.9%1320.88%
Research & Development2.63M2.61M2.51M2.39M3.25M2.36M1.4M1.33M1.42M1.66M2.01M1.56M1.63M1.34M947.37K1.12M1.06M927.24K4.49M4.99M6.51M6.85M2.98M1.04M1.08M947.93K1.14M856.69K1.57M563.04K386.61K
R&D % of Revenue-42.82%36.24%30.88%46.33%46.05%49.23%58.73%35%26.33%67.51%29.58%40.59%67.68%24.7%31.82%30%39.34%34.86%50.01%42.88%48.12%53.61%197.93%697.89%--542.31%408.25%121.3%1208.17%
Other Operating Expenses00001.89M006.96M000000000000000000137.3K485.79K000
Operating Income-3.74M-4.26M-4.01M-8.83M-9.92M-4.94M-5.2M-13.52M-6.87M-4.28M-4.2M-1.7M-2.04M-2.52M27.89K-1.45M-1.2M-2.46M98.19K-5.36M-5.03M-8.29M-6.58M-2.72M-2.86M-2.27M-2.99M-3.3M-5.55M-2.79M-792.17K
Operating Margin %-56.34%-69.89%-57.88%-113.82%-141.36%-96.62%-183.42%-596.23%-169.83%-67.83%-141.17%-32.22%-50.9%-126.97%0.73%-41.46%-34.09%-104.22%0.76%-53.71%-33.1%-58.26%-118.42%-519.07%-1839.24%---2090.76%-1444.36%-600.27%-2475.53%
Operating Income Growth %--6.21%54.56%11.06%-100.81%5.02%61.51%-96.82%-60.66%-1.77%-147.79%16.86%19.14%-9142.82%101.92%-21.22%51.16%-2602.04%101.83%-6.69%39.33%-25.92%-141.95%4.82%-26.11%24.18%9.5%40.54%-99.36%-251.73%-
EBITDA-3.48M-3.88M-3.53M-8.24M-9.38M-4.43M-4.78M-12.51M-5.13M-2.7M-4.14M-1.64M-1.97M-2.47M67.76K-1.41M-1.17M-2.41M952.43K-3.91M-887.95K-2.41M-5.94M-2.71M-2.86M-2.23M-2.85M-2.82M-4.92M-2.68M-771.78K
EBITDA Margin %-52.43%-63.7%-50.99%-106.21%-133.58%-86.57%-168.37%-551.92%-126.9%-42.82%-139.07%-31.15%-49.19%-124.48%1.77%-40.24%-33.15%-102.07%7.4%-39.11%-5.84%-16.93%-106.96%-517.85%-1839.24%---1783.25%-1279.69%-577.95%-2411.8%
EBITDA Growth %5.2%-9.89%57.1%12.17%-111.79%7.3%61.84%-143.84%-90.17%34.78%-152.53%16.83%20.3%-3748.43%104.8%-20.97%51.49%-352.62%124.38%-339.99%63.14%59.48%-119.04%5.04%-27.91%21.65%-1.24%42.76%-83.45%-247.59%-
D&A (Non-Cash Add-back)279.12K377.15K477.53K590.14K546.01K514.07K426.91K1M1.74M1.58M62.64K56.6K68.8K49.58K39.87K42.73K32.82K50.77K854.24K1.46M4.14M5.88M637.12K6.39K031.94K137.3K485.79K633.26K103.62K20.39K
EBIT-3.81M-4.26M-4.02M-8.44M-11.92M-5.05M-5.33M-13.52M-6.87M-4.28M-4.2M-1.67M-1.88M-2.44M27.89K-1.46M-1.2M-2.46M-1.69M-5.36M-5.03M-8.29M-6.44M-2.72M-2.86M-2.27M-2.99M-3.3M-5.55M-2.79M-700K
Net Interest Income-185.1K-313.84K-299.64K-206.74K-10.23K-13.93K-4.31M-1.07M802730-192.19K7-136.48K-24.62K-316.49K-469.93K89.8K-2.55K-829.36K-5.73M-6.51M-600.18K-1.11M-1.16M0-141.34K0-396.6K0-31.32K
Interest Income3.79K3.79K11011.53K2334.08K30.65K1548027301477795.03K241.42K165.71K1.34K3.1K035.96K66.82K4.14K000099.88K04.29K
Interest Expense188.88K317.63K299.75K218.27K10.46K18K4.34M1.07M000192.2K0136.48K24.63K411.53K711.35K89.8K92.52K832.46K5.73M6.55M667.01K1.11M1.16M317.63K141.34K0496.48K035.61K
Other Income/Expense-265.25K-313.84K-312.65K170.47K-2.01M-123.92K-4.47M-1.07M802712.12K-160.13K157.26K-57.66K-24.62K-416.49K550.23K-206.08K86.34K-204.35K-6.05M4.61M1.81M-1.11M-1.16M-317.63K000056.56K
Pretax Income-4M-4.57M-4.32M-8.66M-11.93M-5.07M-9.67M-14.59M-6.87M-4.28M-4.19M-1.86M-1.88M-2.58M3.27K-1.9B-306.79M4.69B119.18K-1.06M-11.08M6.87M-7.24M-3.83M-4.02M-2.58M00000
Pretax Margin %-60.34%-75.04%-62.39%-111.62%-169.94%-99.05%-341.02%-643.37%-169.83%-67.83%-140.76%-35.28%-46.98%-129.88%0.09%-54081.28%-8714.59%199108.51%0.93%-10.58%-72.93%48.29%-130.21%-730.03%-2586.87%------
Income Tax16.5K-16.5K-23K-134.01K-20.43K00016009129121.71K2.81K7442.99K-893.22K-7.15M-20.99K-4.31M0-8.65M655.48K00-300.25K141.34K125.58K396.6K-192.45K31.32K
Effective Tax Rate %-0.41%0.36%0.53%1.55%0.17%0%0%0%-0%0%-0.02%-0.05%-0.09%-0.11%0.21%-0.02%0.29%-0.15%-17.61%407.46%0%-125.85%-9.06%0%0%11.62%-----
Net Income-4.02M-4.59M-4.3M-8.52M-11.91M-5.07M-9.67M-14.59M-6.87M-4.28M-4.19M-1.86M-1.88M-2.58M3.27K-1.9M-306.79K4.69M119.18K-1.06M-11.08M358.06K-7.24M-3.83M-4.02M-2.28M-3.13M-3.43M-5.95M-2.59M-823.49K
Net Margin %-60.58%-75.31%-62.06%-109.89%-169.65%-99.05%-341.02%-643.37%-169.83%-67.83%-140.79%-35.3%-47.02%-130.02%0.09%-54.08%-8.71%199.11%0.93%-10.58%-72.93%2.52%-130.21%-730.03%-2586.87%---2170.26%-1547.48%-558.81%-2573.4%
Net Income Growth %14.67%-6.74%49.53%28.45%-135.11%47.63%33.69%-112.39%-60.66%-2.04%-125.58%1.39%27.05%-79137.37%100.17%-518.54%-106.54%3838.23%111.27%90.46%-3194.65%104.95%-89.16%4.82%-76.02%27.05%8.69%42.39%-129.44%-214.98%-
Net Income (Continuing)-4.02M-4.56M-4.3M-8.52M-11.91M-5.07M-9.67M-14.59M-6.87M-4.28M-4.19M-1.86M-1.88M-2.58M3.27K-1.9M-649.77K-2.66M184.53K-5.57M-11.08M-3.67M-14.35M-3.83M-4.02M-2.28M-3.13M-3.43M-5.95M-2.59M-800K
Discontinued Operations0000000000000000000000000000000
Minority Interest0000000000000000000000000000000
EPS (Diluted)-6.07-6.91-20.88-152.10-272.65-117.03-226.64-1476.89-1053.95-1094.25-1286.65-521.11-551.24-972.201.40-839.28-136.112073.60-919.16-1736.66-8343.37-2647.34-14628.59-7800.84-10926.73-6796.95-12410.39-15708.15-27425.35-12777.41-2807.02
EPS Growth %69.42%66.91%86.27%44.21%-132.97%48.36%84.65%-40.13%3.68%14.95%-146.91%5.47%43.3%-69542.86%100.17%-516.62%-106.56%325.6%47.07%79.19%-215.16%81.9%-87.53%28.61%-60.76%45.23%20.99%42.72%-114.64%-355.19%-
EPS (Basic)--6.91-20.88-152.10-272.65-117.03-226.64-1476.89-1303.65-1291.14-1533.23-558.53-551.24-972.201.40-839.28-136.112073.60-919.16-1736.66-8343.37-3076.31-14628.59-7800.84-10926.73-6796.95-12410.39-15708.15-27425.35-12777.41-2807.02
Diluted Shares Outstanding661.76K664.77K205.99K56.03K43.68K43.29K43.18K9.88K8.06K4.61K3.88K3.82K3.42K2.66K2.31K2.26K2.25K2.1K1.86K1.7K1.45K1.51K1.01K508383336277240217203285
Basic Shares Outstanding661.76K664.77K205.99K56.03K43.68K43.29K43.18K9.88K6.52K3.91K3.26K3.56K3.42K2.66K2.31K2.26K2.25K2.1K1.86K1.7K1.45K1.3K1.01K508383336277240217203285
Dividend Payout Ratio-------------------------------

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidity and dilution risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Volatility Masks Structural Stagnation

As evidenced by the quarterly data, BKYI's top-line performance remains highly erratic, with revenue fluctuating between $0.9M and $2.2M over the last ten quarters, ultimately failing to establish a consistent growth trajectory despite the company's strategic pivot toward recurring software-as-a-service models within the identity management sector.

The revenue profile appears heavily dependent on lumpy, project-based contracts rather than a steady accumulation of recurring subscriptions. This inconsistency suggests that the company has yet to successfully transition its business model into a predictable, high-growth software enterprise.

High Gross Margins Lack Scalability

According to reported financial statements, BKYI maintains a structurally high gross margin, frequently exceeding 75%, yet this efficiency is consistently undermined by an inability to translate these gains into positive operating income, suggesting that the underlying product value is not sufficient to cover corporate overhead.

While the software-centric PortalGuard platform supports strong gross margins, the company's reliance on legacy hardware sales introduces significant volatility in cost of goods sold. Investors should monitor whether the company can sustain these margins as it faces increasing competitive pressure from larger, integrated identity providers.

Operating Leverage Remains Elusive

Based on the income statement history, BKYI exhibits a persistent lack of operating leverage, as SG&A and R&D expenses frequently exceed gross profit, resulting in deep operating losses that have characterized the company's performance for the majority of the observed ten-quarter period.

The fixed cost base appears disproportionately large relative to current revenue levels, indicating that the company is struggling to achieve the necessary scale to reach profitability. Without a significant increase in top-line volume, the current expense structure may continue to erode shareholder value through ongoing operational deficits.

Sustainability of Current Business Model

As highlighted by the persistent negative operating margins and the recent $2.7M cash position against significant quarterly burn, the company's financial narrative faces a critical challenge regarding its long-term viability without further dilutive capital raises or a dramatic improvement in operational efficiency.

Short-term observers may focus on the potential for large-scale international contract wins, but the historical data suggests these are often offset by high implementation costs and collection risks. The fundamental risk remains that the company's identity orchestration value proposition is being commoditized by larger, better-capitalized incumbents.

BKYI — Frequently Asked Questions

Quick answers to the most common questions about buying BKYI stock.

What was BIO-key International, Inc.'s (BKYI) revenue in 2025?

For fiscal year 2025, BIO-key International, Inc. (BKYI) reported total revenue of $6.1M. This represents a 18947.2% increase compared to $0.0M in 1996.

Is BIO-key International, Inc. (BKYI) profitable?

BIO-key International, Inc. (BKYI) reported a net loss of $4.6M for the fiscal year ending 2025.

What is BIO-key International, Inc.'s operating profit margin?

BIO-key International, Inc. (BKYI) reported an operating income of $-4.3M, resulting in an operating profit margin of -69.9%. This margin reflects the operational efficiency of the business before interest and taxes.

What is BIO-key International, Inc.'s gross profit and gross margin?

BIO-key International, Inc. (BKYI) generated $4.7M in gross profit for the year, representing a gross profit margin of 77.5%. This demonstrates the company's core pricing power and production efficiency.